Cellectar Biosciences Ownership | Who Owns Cellectar Biosciences?
Cellectar Biosciences Ownership Summary
Cellectar Biosciences is owned by 0.09% institutional investors, 1.71% insiders, and 98.20% retail investors. Adar1 capital management is the largest institutional shareholder, holding 0.09% of CLRB shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.33% of its assets in Cellectar Biosciences shares.
CLRB Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Cellectar Biosciences | 0.09% | 1.71% | 98.20% |
Sector | Healthcare Stocks | 278.45% | 10.60% | -189.04% |
Industry | Biotech Stocks | 63.84% | 10.66% | 25.50% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Adar1 capital management | 40.23K | 0.09% | $12.68K |
Two sigma securities | - | - | - |
Altium capital management lp | - | - | - |
Bfsg | - | - | - |
Bnp paribas arbitrage, snc | - | - | - |
Citigroup | - | - | - |
Enrich financial partners | - | - | - |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Adar1 capital management | 40.23K | 0.00% | $12.68K |
Two sigma securities | - | - | - |
Altium capital management lp | - | - | - |
Bfsg | - | - | - |
Bnp paribas arbitrage, snc | - | - | - |
Citigroup | - | - | - |
Enrich financial partners | - | - | - |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Enrich financial partners | - | - | -102.00 |
Citigroup | - | - | -660.00 |
Bfsg | - | - | -1.00K |
Bnp paribas arbitrage, snc | - | - | -16.82K |
Two sigma securities | - | - | -51.95K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Adar1 capital management | 40.23K | 0.00% | -545.03K |
Altium capital management lp | - | - | -215.00K |
Two sigma securities | - | - | -51.95K |
Bnp paribas arbitrage, snc | - | - | -16.82K |
Bfsg | - | - | -1.00K |
Sold Out
Holder | Change |
---|---|
Enrich financial partners | -102.00 |
Citigroup | -660.00 |
Bfsg | -1.00K |
Bnp paribas arbitrage, snc | -16.82K |
Two sigma securities | -51.95K |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Mar 31, 2025 | 1 | -96.88% | 40,228 | -99.21% | - | 0.05% | - | -100.00% | 1 | -83.33% |
Dec 31, 2024 | 32 | -13.51% | 5,096,844 | -63.61% | 13 | 1.10% | 17 | 21.43% | 6 | -33.33% |
Sep 30, 2024 | 37 | -7.50% | 14,004,954 | 20.80% | 35 | 3.40% | 14 | -36.36% | 9 | 12.50% |
Jun 30, 2024 | 40 | -21.57% | 11,593,733 | 26.98% | 32 | 3.34% | 22 | -38.89% | 8 | 60.00% |
Mar 31, 2024 | 51 | 96.15% | 9,130,425 | 6.12% | 31 | 1.46% | 36 | 140.00% | 5 | - |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Vanguard US Total Market Shares ETF | 1.07M | 2.33% | - |
Vanguard Total Stock Mkt Idx Inv | 1.07M | 2.33% | - |
Vanguard Institutional Extnd Mkt Idx Tr | 568.75K | 1.23% | - |
Fidelity Extended Market Index | 229.76K | 0.50% | -2.20K |
BlackRock Extended Equity Market K | 72.26K | 0.20% | -31.00 |
iShares Micro-Cap ETF | 73.44K | 0.16% | - |
Extended Equity Market Fund K | 71.50K | 0.16% | 219.00 |
Fidelity Total Market Index | 61.94K | 0.13% | - |
Spartan Extended Market Index Pool F | 58.87K | 0.13% | 2.20K |
Spartan Extended Market Index Pool E | 56.68K | 0.12% | 27.44K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Jan 10, 2025 | Longcor Jarrod | Chief Operating Officer | Buy | $8.40K |
Sep 14, 2021 | Swirsky Douglas J | - | Buy | $26.00K |
Sep 03, 2021 | DRISCOLL FREDERICK W | - | Buy | $20.24K |
Mar 18, 2021 | NEIS JOHN | - | Sell | $706.25K |
Mar 17, 2021 | NEIS JOHN | - | Sell | $1.78M |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2023 Q2 | - | - |
2023 Q1 | - | - |
2022 Q4 | - | - |
2022 Q2 | - | - |
2022 Q1 | - | - |
CLRB Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools